NASDAQ:CPRX
Catalyst Pharmaceuticals Stock News
$15.15
-0.240 (-1.56%)
At Close: Jun 25, 2024
Biotech's Blockbuster Week: 3 Stocks to Watch
05:32pm, Friday, 13'th Jan 2023 Zacks Investment Research
In a strong week for the market, biotech dominated. Today we will cover 3 promising stocks in the space.
2 Biotechs Making Waves With A Single Product in their Pipeline
10:10am, Thursday, 12'th Jan 2023
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.
Is Most-Watched Stock Catalyst Pharmaceuticals, Inc. (CPRX) Worth Betting on Now?
02:00pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Catalyst (CPRX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Most-Watched Stock Catalyst Pharmaceuticals, Inc. (CPRX) Worth Betting on Now?
10:32am, Tuesday, 10'th Jan 2023
Catalyst (CPRX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
01:30pm, Thursday, 05'th Jan 2023 Zacks Investment Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?
08:05am, Wednesday, 04'th Jan 2023
As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience. The post Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?
Sector Leaders End Tough Year With Thin Ranks
03:04pm, Friday, 30'th Dec 2022
New Year starts with just three top stocks that meet IBD Sector Leaders' stringent criteria: Super Micro Computer, KLA and Catalyst Pharma. The post Sector Leaders End Tough Year With Thin Ranks appea
Biotech: 3 Profitable Bios Worth Owning
07:19pm, Wednesday, 28'th Dec 2022 Zacks Investment Research
The biotechnology space can be a difficult area to generate profits. Drugs take years to develop and often fail FDA approval. Today we will look at three top biotech stocks that are very profitable an
Biotech: 3 Profitable Bios Worth Owning
03:22pm, Wednesday, 28'th Dec 2022
The biotechnology space can be a difficult area to generate profits. Drugs take years to develop and often fail FDA approval.
Biotech And Medical Stocks Leading Performers As 2022 Draws To A Close
03:49pm, Friday, 23'rd Dec 2022
These leading biotech stocks have had a good quarter and some may have room to run, while for others it's time to ring the register. The post Biotech And Medical Stocks Leading Performers As 2022 Draw
HC Wainwright & Co. Maintains Buy Rating for Catalyst Pharmaceuticals: Here's What You Need To Know
05:04pm, Wednesday, 21'st Dec 2022 Benzinga
HC Wainwright & Co. has decided to maintain its Buy rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) and raise its price target from $18.00 to $24.00.
Shares of Catalyst Pharmaceuticals are trading up
If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now
01:30pm, Tuesday, 20'th Dec 2022 Zacks Investment Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
09:10pm, Monday, 19'th Dec 2022 GlobeNewswire Inc.
Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product
This Growth Stock's Jaw-Dropping Run-Up Is Smashing Tesla's
09:30pm, Friday, 16'th Dec 2022 The Motley Fool
It's practically printing cash, and even more is on the way.
This Growth Stock's Jaw-Dropping Run-Up Is Smashing Tesla's
04:30pm, Friday, 16'th Dec 2022
It's practically printing cash, and even more is on the way.
